These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37173620)

  • 1. HbA1c as a shared treatment goal in type 2 diabetes? A secondary analysis of the DEBATE trial.
    Santos S; Pentzek M; Altiner A; Daubmann A; Drewelow E; Helbig C; Löffler C; Löscher S; Wegscheider K; Abholz HH; Wilm S; Wollny A
    BMC Prim Care; 2023 May; 24(1):115. PubMed ID: 37173620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-centered communication and shared decision making to reduce HbA1c levels of patients with poorly controlled type 2 diabetes mellitus - results of the cluster-randomized controlled DEBATE trial.
    Wollny A; Altiner A; Daubmann A; Drewelow E; Helbig C; Löscher S; Pentzek M; Santos S; Wegscheider K; Wilm S; Löffler C
    BMC Fam Pract; 2019 Jun; 20(1):87. PubMed ID: 31238871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
    Bae JP; Duan R; Fu H; Hoogwerf BJ
    Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared decision making and patient-centeredness for patients with poorly controlled type 2 diabetes mellitus in primary care-results of the cluster-randomised controlled DEBATE trial.
    Wollny A; Löffler C; Drewelow E; Altiner A; Helbig C; Daubmann A; Wegscheider K; Löscher S; Pentzek M; Wilm S; Feldmeier G; Santos S
    BMC Fam Pract; 2021 May; 22(1):93. PubMed ID: 33992088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of shared goal setting and decision making to achieve treatment targets in type 2 diabetes patients: A cluster-randomized trial (OPTIMAL).
    Den Ouden H; Vos RC; Rutten GEHM
    Health Expect; 2017 Oct; 20(5):1172-1180. PubMed ID: 28544171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.
    Yang J; Xiao W; Guo L; Li Q; Zhong L; Yang J; Yang J; Gao Y; Tian Q; Hong T
    Acta Diabetol; 2020 Aug; 57(8):991-1000. PubMed ID: 32206903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial.
    Lauffenburger JC; Ghazinouri R; Jan S; Makanji S; Ferro CA; Lewey J; Wittbrodt E; Lee J; Haff N; Fontanet CP; Choudhry NK
    PLoS One; 2019; 14(4):e0214754. PubMed ID: 30939143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States.
    Fernandes G; Sawhney B; Hannachi H; Liu J; Wang T; Fu AZ; Iglay K; McNeill A; Rajpathak S
    Curr Med Res Opin; 2020 May; 36(5):741-748. PubMed ID: 31990206
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Lauffenburger JC; Lewey J; Jan S; Makanji S; Ferro CA; Krumme AA; Lee J; Ghazinouri R; Haff N; Choudhry NK
    JAMA Netw Open; 2019 Mar; 2(3):e190657. PubMed ID: 30874782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a Precision Medicine Analysis of a Behavioral Counseling Strategy to Improve Adherence to Diabetes Self-management Among Youth: A Post Hoc Analysis of the FLEX Trial.
    Kahkoska AR; Lawson MT; Crandell J; Driscoll KA; Kichler JC; Seid M; Maahs DM; Kosorok MR; Mayer-Davis EJ
    JAMA Netw Open; 2019 May; 2(5):e195137. PubMed ID: 31150087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized HbA
    Lautsch D; Boggs R; Wang T; Gonzalez C; Milligan G; Rajpathak S; Malkani S; McLeod E; Carroll J; Higgins V
    Adv Ther; 2022 Feb; 39(2):1016-1032. PubMed ID: 34951678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Collaborative Goal Setting With Enhanced Education for Managing Diabetes-Associated Distress and Hemoglobin A1c Levels: A Randomized Clinical Trial.
    Woodard L; Amspoker AB; Hundt NE; Gordon HS; Hertz B; Odom E; Utech A; Razjouyan J; Rajan SS; Kamdar N; Lindo J; Kiefer L; Mehta P; Naik AD
    JAMA Netw Open; 2022 May; 5(5):e229975. PubMed ID: 35507345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial.
    House A; Bryant L; Russell AM; Wright-Hughes A; Graham L; Walwyn R; Wright JM; Hulme C; O'Dwyer JL; Latchford G; Meer S; Birtwistle JC; Stansfield A; Ajjan R; Farrin A
    Health Technol Assess; 2018 May; 22(26):1-328. PubMed ID: 29845932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets.
    Dalal MR; Grabner M; Bonine N; Stephenson JJ; DiGenio A; Bieszk N
    Diabetes Res Clin Pract; 2016 Nov; 121():17-26. PubMed ID: 27616634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study.
    Tourkmani AM; Abdelhay O; Alkhashan HI; Alaboud AF; Bakhit A; Elsaid T; Alawad A; Alobaikan A; Alqahtani H; Alqahtani A; Mishriky A; Bin Rsheed A; Alharbi TJ
    BMC Fam Pract; 2018 Jan; 19(1):1. PubMed ID: 29291706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0.
    Owens DR; Landgraf W; Frier BM; Zhang M; Home PD; Meneghini L; Bolli GB
    Diabetes Obes Metab; 2019 Feb; 21(2):321-329. PubMed ID: 30520217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
    Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
    Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
    Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
    Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.